Theriva Biologics, a broadened clinical-stage organization creating therapeutics intended to treat malignant growth and related sicknesses in areas of high neglected need, declared that the Free Information Observing Panel (IDMC) suggested the...
pharmaceutical companies, high-quality biologics ,partnership
Bristol Myers Squibb has launched two clinical trials for neoadjuvant Opdivo (nivolumab) and adjuvant Opdivo and postoperative chemotherapy for the treatment of unresectable stages IIA to IIIB small resectable breast cancer (NSCLC).
BioNTech SE, a next-generation immunotherapy company developing new treatments for cancer and other malignancies, and Autolus Therapeutics plc, a clinical-stage biopharmaceutical company developing clinical T-medicine.
Chugai Pharmaceutical Co., Ltd. said. 'Crobalimab,' an anti-C5 monoclonal antibody discovered by Chugai, has been approved by China's National Medical Products Administration (NMPA) as a treatment for adults and adolescents (adolescents or 12 years).
Biocomposites, a global clinical gadgets organization that designers, makes and markets world driving items for use in contamination the executives in bone and delicate tissue, reports the send off of two stage II clinical preliminaries of...
Precious Systems, a leader in digital technology and business innovation, has partnered with Microsoft to launch an innovative population health management (PHM) solution.
Narayana Health, one of India's leading healthcare providers, is proud to open its luxury healthcare facility at Hebbagodi in Electronic City, Bangalore.
Asian Institute of Nephrology and Urology (AINU), a leading urology and nephrology network of AHH private hospital, has announced the opening a state-of-the-art male sexual and reproductive health center at AINU, Chennai Hospital.
StimLabs, founded in 2015 to advance regenerative medicine, announced the FDA 510(k) clearance of Corplex P, a medical device derived from the human umbilical cord.
, CDSCO.jpg)
